Danaher Total Long-Term Assets 2010-2025 | DHR
Danaher total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
- Danaher total long-term assets for the quarter ending March 31, 2025 were $69.591B, a 0.81% increase year-over-year.
- Danaher total long-term assets for 2024 were $68.045B, a 3.55% decline from 2023.
- Danaher total long-term assets for 2023 were $70.551B, a 3.04% increase from 2022.
- Danaher total long-term assets for 2022 were $68.467B, a 4.29% decline from 2021.
| Danaher Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $68,045 |
| 2023 | $70,551 |
| 2022 | $68,467 |
| 2021 | $71,536 |
| 2020 | $62,359 |
| 2019 | $36,486 |
| 2018 | $40,739 |
| 2017 | $39,799 |
| 2016 | $38,630 |
| 2015 | $40,386 |
| 2014 | $27,560 |
| 2013 | $25,559 |
| 2012 | $25,353 |
| 2011 | $23,677 |
| 2010 | $16,152 |
| 2009 | $14,375 |
| Danaher Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $69,591 |
| 2024-12-31 | $68,045 |
| 2024-09-30 | $70,555 |
| 2024-06-30 | $68,946 |
| 2024-03-31 | $69,030 |
| 2023-12-31 | $70,551 |
| 2023-09-30 | $66,529 |
| 2023-06-30 | $67,441 |
| 2023-03-31 | $68,508 |
| 2022-12-31 | $68,467 |
| 2022-09-30 | $66,780 |
| 2022-06-30 | $68,577 |
| 2022-03-31 | $70,722 |
| 2021-12-31 | $71,536 |
| 2021-09-30 | $71,722 |
| 2021-06-30 | $62,635 |
| 2021-03-31 | $61,414 |
| 2020-12-31 | $62,359 |
| 2020-09-30 | $60,350 |
| 2020-06-30 | $58,925 |
| 2020-03-31 | $57,788 |
| 2019-12-31 | $36,486 |
| 2019-09-30 | $41,177 |
| 2019-06-30 | $41,718 |
| 2019-03-31 | $41,694 |
| 2018-12-31 | $40,739 |
| 2018-09-30 | $40,889 |
| 2018-06-30 | $41,143 |
| 2018-03-31 | $40,070 |
| 2017-12-31 | $39,799 |
| 2017-09-30 | $39,591 |
| 2017-06-30 | $39,390 |
| 2017-03-31 | $38,926 |
| 2016-12-31 | $38,630 |
| 2016-09-30 | $34,804 |
| 2016-06-30 | $40,273 |
| 2016-03-31 | $40,638 |
| 2015-12-31 | $40,386 |
| 2015-09-30 | $40,776 |
| 2015-06-30 | $27,332 |
| 2015-03-31 | $27,298 |
| 2014-12-31 | $27,560 |
| 2014-09-30 | $25,546 |
| 2014-06-30 | $26,145 |
| 2014-03-31 | $25,638 |
| 2013-12-31 | $25,559 |
| 2013-09-30 | $25,698 |
| 2013-06-30 | $24,878 |
| 2013-03-31 | $24,559 |
| 2012-12-31 | $25,353 |
| 2012-09-30 | $24,677 |
| 2012-06-30 | $24,560 |
| 2012-03-31 | $23,878 |
| 2011-12-31 | $23,677 |
| 2011-09-30 | $24,304 |
| 2011-06-30 | $24,959 |
| 2011-03-31 | $16,903 |
| 2010-12-31 | $16,152 |
| 2010-09-30 | $16,037 |
| 2010-06-30 | $15,034 |
| 2010-03-31 | $15,340 |
| 2009-12-31 | $14,375 |
| 2009-09-30 | $13,963 |
| 2009-06-30 | $13,534 |
| 2009-03-31 | $13,176 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $137.452B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $85.620B | 11.05 |
| CVS Health (CVS) | United States | $80.443B | 10.00 |
| Cencora (COR) | United States | $56.509B | 19.66 |
| Natera (NTRA) | United States | $21.868B | 0.00 |
| DiDi Global (DIDIY) | China | $21.650B | 32.86 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $12.848B | 13.60 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.645B | 0.00 |
| CochLear (CHEOY) | Australia | $11.378B | 0.00 |
| ICON (ICLR) | Ireland | $10.802B | 10.04 |
| Revvity (RVTY) | United States | $10.730B | 18.47 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| Doximity (DOCS) | United States | $10.051B | 46.53 |
| HealthEquity (HQY) | United States | $8.975B | 39.30 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| Medpace Holdings (MEDP) | United States | $8.797B | 23.36 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.802B | 13.33 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.121B | 38.15 |
| Bausch + Lomb (BLCO) | Canada | $4.065B | 23.96 |
| Sotera Health (SHC) | United States | $3.486B | 19.81 |
| Alignment Healthcare (ALHC) | United States | $3.035B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.984B | 38.80 |
| Concentras Parent (CON) | United States | $2.776B | 16.04 |
| Organon (OGN) | United States | $2.454B | 2.61 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.078B | 80.01 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.884B | 41.47 |
| PACS (PACS) | United States | $1.554B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.407B | 28.14 |
| Teladoc Health (TDOC) | United States | $1.239B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.186B | 9.02 |
| Establishment Labs Holdings (ESTA) | $1.061B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.971B | 15.16 |
| Agilon Health (AGL) | United States | $0.940B | 0.00 |
| Nutex Health (NUTX) | United States | $0.825B | 12.46 |
| AMN Healthcare Services Inc (AMN) | United States | $0.783B | 7.33 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.620B | 4.18 |
| LifeMD (LFMD) | United States | $0.575B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| SBC Medicals (SBC) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.491B | 11.07 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.254B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| DocGo (DCGO) | United States | $0.151B | 24.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.094B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| ModivCare (MODV) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |